Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Cash Flows from Operating Activities:
Net income (loss)	$ 375,868	$ (402,758)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	2,559	8,805
Unrealized gain on equity securities	(727,203)	0
Unrealized gain on equity securities		0
Amortization of investment securities, net	11,881	13,947
Deferred acquisition costs capitalized	(74,962)	(64,638)
Deferred acquisition costs amortized	62,903	90,355
Value of business acquired amortized	5,076	5,076
Interest credited on deposit type contracts	160,494	131,779
(Increase) decrease in operating assets:
Investment income due and accrued	(24,508)	(22,934)
Reinsurance related assets	60,531	66,976
Other assets	17,033	33,164
Increase (decrease) in operating liabilities:
Policyowner benefit reserves	631,551	736,552
Dividend accumulation	(9,519)
Advance premiums	(6,587)	58,942
Other liabilities	(3,279)	6,833
Accounts payable and accrued expenses	12,463	(624)
Net cash provided by operating activities	494,301	661,475
Cash Flows from Investing Activities:
Purchase of fixed income investments	(615,289)	(715,128)
Purchase of equity investments	(173,630)	(300,175)
Proceeds from fixed income sales and repayments	52,582	28,126
Interest on policy loans	(674)	(619)
Increase in policy loans	(222)	1,330
Net cash used in investing activities	(737,233)	(986,466)
Cash Flows from Financing Activities:
Receipts on deposit-type contracts	965,438	1,064,900
Withdrawals on deposit-type contracts	(471,668)	(424,178)
Proceeds received from issuance of common stock, net of costs of issuance	156,890	203,811
Net cash provided by financing activities	650,660	844,533
Net increase in cash and cash equivalents	407,728	519,542
Cash and Cash Equivalents:
Beginning	2,077,646	651,809
Ending	$ 2,485,374	$ 1,171,351